HRD1-mediated METTL14 degradation regulates m6A mRNA modification to suppress ER proteotoxic liver disease is a research paper published in Molecular Cell (2021). On theSindex it has a DataRank of 0. It has been cited 77 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: CA221007
National Institutes of Health
Grant: DK120330
National Institutes of Health
Grant: DK126908
National Institutes of Health
Grant: CA257520
National Institutes of Health
Grant: HD104904
National Institutes of Health
Grant: CA232347
National Institutes of Health
Grant: DK121997
National Institutes of Health
Grant: R35ES031575
National Institutes of Health
Grant: R01DK093807
National Institutes of Health
Grant: RM1 HG008935
NIAID NIH HHS
Grant: R01 AI167272
NCI NIH HHS
Grant: R01 CA257520
NIDDK NIH HHS
Grant: R01 DK121997
NICHD NIH HHS
Grant: R21 HD104904
NIDDK NIH HHS
Grant: T32 DK007169
NCI NIH HHS
Grant: F32 CA221007
NCI NIH HHS
Grant: R01 CA232347
NIDDK NIH HHS
Grant: R01 DK126908
NIDDK NIH HHS
Grant: R01 DK120330
Howard Hughes Medical Institute
FWCI
3.11
Citation Percentile
0.9%
Influential Citations
1
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of CHOP regulated by METTL14-m6A affects cell cycle arrest and regorafenib sensitivity in HCC cells
Additional file 1 of CHOP regulated by METTL14-m6A affects cell cycle arrest and regorafenib sensitivity in HCC cells